The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade

201688 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Cell Death and Differentiation

Volume 23, Issue 6, pp. 1004-1015

Field-Weighted Citation Impact: 4.04